Medicare Part D prescription drug plan premiums have increased while Donald Trump claimed credit for lowering drug prices.

"Heading: Other Reasons for the Drop in Prices The CPI’s prescription drug index dropped about 0.2% in February before registering a bigger decline of 1.5% in March. Whether people notice a difference in what they’re actually paying at the pharmacy, of course, generally has more to do with the specific features of their insurance plan, Ballreich said. “That will have a much more influential effect on them as patients, rather than general drug pricing trends.”"

"President Donald Trump and other administration officials are claiming credit for a recent drop in prescription drug prices, citing deals they’ve struck with drugmakers and the launch of the online direct-to-consumer platform TrumpRx. But experts are skeptical those measures have had much impact on prices overall, and they say other factors likely explain most of the decline. Trump and his allies were quick to celebrate when the latest consumer price data from the Bureau of Labor Statistics, released in mid-August, showed prescription drug prices falling 3.1% over the past year. The data measure prices paid by consumers and insurers at retail, internet or mail-order pharmacies."

"Heading: FULL ANSWER “We understand that outside organizations without plan bid information have voiced concerns, however our data shows that plan bids have stabilized,” the spokesperson told us in an email. “[A]mong the roughly quarter of Medicare beneficiaries enrolled in plans the previous demo impacted, over 85% of beneficiaries will have access to a Part D plan that is either lower cost or less than a $10 increase next year.” The spokesperson also said all of those beneficiaries “will have access to at least three prescription drug plan options with total monthly premiums of $50 or less.”"

"Q: Is President Donald Trump really cutting Medicare subsidies? A: The Trump administration recently announced that it is ending a temporary subsidy that has reduced premiums for Medicare Part D standalone prescription drug plans. The subsidy, originally slated to run through at least 2027, was put into place by the Biden administration to offset expected premium increases after major changes to the Part D benefit. Analysts say some Medicare beneficiaries could see higher Part D premiums as a result."

"Heading: Other Reasons for the Drop in Prices The CPI’s prescription drug index dropped about 0.2% in February before registering a bigger decline of 1.5% in March. Whether people notice a difference in what they’re actually paying at the pharmacy, of course, generally has more to do with the specific features of their insurance plan, Ballreich said. “That will have a much more influential effect on them as patients, rather than general drug pricing trends.”"

"President Donald Trump and other administration officials are claiming credit for a recent drop in prescription drug prices, citing deals they’ve struck with drugmakers and the launch of the online direct-to-consumer platform TrumpRx. But experts are skeptical those measures have had much impact on prices overall, and they say other factors likely explain most of the decline. Trump and his allies were quick to celebrate when the latest consumer price data from the Bureau of Labor Statistics, released in mid-August, showed prescription drug prices falling 3.1% over the past year. The data measure prices paid by consumers and insurers at retail, internet or mail-order pharmacies."